Rosuvastatin--a highly effective new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: review of clinical trial data at 10-40 mg doses in dyslipidemic patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples